Investor Relations
The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Recent Press Releases
03-09-10
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
03-04-10
Aastrom Regains Compliance With NASDAQ Minimum Bid Requirement
more »
Events
05-11-10
World Stem Cells & Regenerative Medicine Congress 2010
02-24-10
Conference Call to Discuss Interim Results from RESTORE-CLI Clinical Trial
more »
|